Boeing saw a 20% bounce but faces risks in 2025. Read why BA stock could suffer from further dilution and a likely credit ...

Kiromic BioPharma (KRBP), a developer of cell therapies for the treatment of solid tumors, has filed to raise around $17M ...

Intel stock surged on rumors of a potential buyout involving Elon Musk, suggesting a 20%-30% premium. Click here to read more ...

Meta’s focus on efficiency and strong digital advertising position supports growth. Find out why META stock offers attractive ...

An analysis of Bill Ackman's presentation on Fannie Mae and Freddie Mac, cautioning investors on volatility and long-term ...

Investment-grade corporate bonds can be a defensive allocation but consider two key factors: wrapper and duration. Click here ...

Herbalife underperformed other small-caps and consumer staple stocks, while witnessing almost a 50% contraction in price YoY.

Analysis of H&R Block, Inc.'s Q2 earnings, diversification efforts, and impact of new administration's policies on the ...

Capital One Financial (COF) reports Q4 earnings, with adjusted EPS beating expectations. Net revenue, interest income, and ...

Nike’s shift to D2C and weak innovation hurt growth. Read why NKE stock’s low valuation doesn’t make it a favorable ...

Tempus AI is projected to achieve 30% YoY top line growth in Q4 2024 as presented in its preliminary results. Click here to ...

Intel's takeover rumors, particularly involving Elon Musk, have altered its risk/reward profile. Click here to read an ...